US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carisma Therapeutics

0.2152

-0.0027-1.24%

Volume:281.67K

Turnover:61.97K

Market Cap:8.99M

PE:-0.15

High:0.2285

Open:0.2179

Low:0.2058

Close:0.2179

Loading ...

Overview Company News Filings

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

Carisma Therapeutics Is Maintained at Buy by D. Boral Capital

Carisma Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Carisma Therapeutics Board Approves Revised Operating Plan; Reduces Workforce

MT Newswires Live

Carisma Therapeutics Exploring Strategic Alternatives After Job Cuts

Carisma Therapeutics Inc: Has Paused All Research and Development Activities at This Time, Pending Outcome of Review

THOMSON REUTERS

Carisma Therapeutics Inc: Has Reduced Operations to Core Functions Necessary to Support This Strategic Review

THOMSON REUTERS

Carisma Therapeutics Provides Corporate Updates

THOMSON REUTERS

Carisma Therapeutics Inc: Estimates That It Has Cash and Cash Equivalents Sufficient to Fund Its Operations Into Second Half of 2025

THOMSON REUTERS

Carisma : May Engage External Advisors to Support Evaluation of Strategic Alternatives, Prepare for Potential Wind-Down of Operations, IF Necessary

THOMSON REUTERS

Carisma Therapeutics Inc: Has Reduced Its Workforce, Retaining Only Those Employees Deemed Essential to Pursue Strategic Alternatives

THOMSON REUTERS

Carisma Therapeutics Inc: to Explore Strategic Alternatives to Advance Liver Fibrosis and Oncology Assets and Reduce Operational Cash Burn

THOMSON REUTERS

Carisma Therapeutics Provides Corporate Updates

Carisma Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview

Carmila SAS (CARM) Receives a Buy from Kepler Capital

Kepler Capital Sticks to Its Buy Rating for Carmila SAS (CARM)

Carisma Therapeutics Is Maintained at Buy by D. Boral Capital

BRIEF-Carisma Therapeutics Appoints Natalie Mcandrew As Principal Financial Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CARM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CARM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CARM\",,,,,undefined,":{"symbol":"CARM","market":"US","secType":"STK","nameCN":"Carisma Therapeutics","latestPrice":0.2152,"timestamp":1745524800000,"preClose":0.2179,"halted":0,"volume":281673,"delay":0,"floatShares":30260519,"shares":41788096,"eps":-1.458816,"marketStatus":"Pre-Mkt","change":-0.0027,"latestTime":"04-25 07:32:18 EDT","open":0.2179,"high":0.2285,"low":0.2058,"amount":61969.288094280004,"amplitude":0.104176,"askPrice":0.2485,"askSize":100,"bidPrice":0.1855,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.458816,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745587800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2152,"postHourTrading":{"tag":"盘后","latestPrice":0.225,"preClose":0.2152,"latestTime":"18:30 EDT","volume":114,"amount":25.65,"timestamp":1745533848971},"volumeRatio":2.158968316578515},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CARM\",,,,,undefined,":{"symbol":"CARM","floatShares":30260519,"roa":"-62.68%","roe":"-362.79%","lyrEps":-1.458816,"volumeRatio":2.158968316578515,"shares":41788096,"dividePrice":0,"high":0.2285,"amplitude":0.104176,"preClose":0.2179,"low":0.2058,"week52Low":0.1601,"pbRate":"-0.32","psRate":"0.46","week52High":1.9,"institutionHeld":0,"latestPrice":0.2152,"eps":-1.458816,"divideRate":0,"volume":281673,"delay":0,"ttmEps":-1.458816,"open":0.2179,"prevYearClose":0.4188,"prevWeekClose":0.192,"prevMonthClose":0.31,"prevQuarterClose":0.31,"fiveDayClose":0.2009,"twentyDayClose":0.3851,"sixtyDayClose":0.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CARM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525090470","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2525090470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525090470?lang=en_us&edition=fundamental","pubTime":"2025-04-07 18:00","pubTimestamp":1744020000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Dave & Buster's Ent                             4Q       .67       AMC. ·Kura Sushi USA                                  2Q      (.11)  4:05 PM. ·RPM Intl Inc.                                    3Q       .50   6:45 AM. ·Delta Air Lines Inc.                             1Q       .44   6:30 AM. ·Simply Gd Foods                                 2Q       .40   7:00 AM. ·Byrna Tech Inc.                                 1Q       .05   8:00 AM. ·Bank of N Y Mellon                                1Q      1.51   6:30 AM. ·Wells Fargo & Co                                 1Q      1.23   7:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WAFD","BK4212","LU0238689110.USD","LU2552382058.USD","AMC","MAMA","LU1201861249.SGD","LEVI","BK4500","CRVO","LU0980610538.SGD","LU2242649171.HKD","DAL","LU0128525689.USD","TBBB","TLRY","BSVN","LU0787776722.HKD","LU2361044865.SGD","LU0795875169.SGD","BYRN","FAST","BK4113","IE00B1XK9C88.USD","RPM","KMX","BLK","UNTY","BK","LU2106854487.HKD","LOVE","NRIX","SMPL","STZ","KRUS","LU1481011671.HKD","CARM","IE00BN8TJ469.HKD","LU2264538146.SGD","LU0098860793.USD","LAKE","PGR","PLAY","CALM","NEOG","LU0052756011.USD","LU1551013425.SGD","LU0320765489.SGD","LU1064131342.USD","PSMT"],"gpt_icon":0},{"id":"2524239365","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2524239365","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524239365?lang=en_us&edition=fundamental","pubTime":"2025-04-03 18:00","pubTimestamp":1743674400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·MSC Indus Dir.                                   2Q       .68   6:30 AM. ·Dave & Buster's Ent                             4Q       .69       AMC. ·Kura Sushi USA                                  2Q      (.10)  4:05 PM. ·RPM Intl Inc.                                    3Q       .51   6:45 AM. ·Delta Air Lines Inc.                             1Q       .44   6:30 AM. ·Simply Gd Foods                                 2Q       .40   7:00 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4086","BK4202","CALM","RDUS","SMPL","LU0203345920.USD","BK4212","LU0052756011.USD","LEVI","BK4568","LAKE","LU0310800965.SGD","LU1815336091.USD","CAG","BK4559","IE00B66KJ199.SGD","AMC","TLRY","PSMT","TBBB","DAL","LW","NRIX","MAMA","STZ","MSM","BK4152","BK4585","SLP","PLAY","AYI","KRUS","APOG","BK4113","CRVO","LU0128525689.USD","LU1267930227.SGD","NEOG","BK4139","LU0203347892.USD","RPM","CARM","BK4155","BK4557","LNN","BK4504","LU2552382132.HKD","LU0757428866.USD","BK4096","BK4167"],"gpt_icon":0},{"id":"2524462035","title":"Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2524462035","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524462035?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:54","pubTimestamp":1743594873,"startTime":"0","endTime":"0","summary":"Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.NasdaqGM:CARM Earnings and Revenue Growth April 2nd 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 8.3%. Earnings per share  also missed analyst estimates by 22%.Looking ahead, revenue is expected to decline by 57% p.a. on average during the next 3 years, while revenues in the Biotechs industry in the US are expected to grow by 19%.The company's shares are down 42% from a week ago.It is worth noting though that we have found 5 warning signs for Carisma Therapeutics (2 can't be ignored!) that you need to take into consideration.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/carisma-therapeutics-full-2024-earnings-115433287.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CARM"],"gpt_icon":0},{"id":"2524254192","title":"Carisma Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2524254192","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524254192?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:27","pubTimestamp":1743506820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CARM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 07:27 ET (11:27 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARM"],"gpt_icon":0},{"id":"2524909462","title":"Carisma Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2524909462","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524909462?lang=en_us&edition=fundamental","pubTime":"2025-04-01 07:04","pubTimestamp":1743462246,"startTime":"0","endTime":"0","summary":"Carisma Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryCarisma Therapeutics Inc CARM.OQ reported a quarterly adjusted loss of 42 cents per share for the quarter e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL5N3QE1UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARM"],"gpt_icon":0},{"id":"2524908445","title":"Carisma Therapeutics Board Approves Revised Operating Plan; Reduces Workforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2524908445","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524908445?lang=en_us&edition=fundamental","pubTime":"2025-04-01 05:27","pubTimestamp":1743456455,"startTime":"0","endTime":"0","summary":"Carisma Therapeutics  said late Monday that its board approved a revised operating plan to evaluate alternatives while reducing operational cash burn.The company said it has reduced its workforce, retaining only those deemed essential to \"pursue strategic alternatives.\" It has cut operations to core functions necessary to support the strategic review.With these actions, the company estimates it has enough cash and cash equivalents to fund operations into H2.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CARM"],"gpt_icon":0},{"id":"2524908432","title":"Carisma Therapeutics Exploring Strategic Alternatives After Job Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2524908432","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524908432?lang=en_us&edition=fundamental","pubTime":"2025-04-01 05:24","pubTimestamp":1743456240,"startTime":"0","endTime":"0","summary":"Carisma Therapeutics plans to explore strategic alternatives after cutting 95% of its workforce.The Philadelphia biotechnology company said Monday its board of directors approved a revised operating plan. The plan is aimed at maximizing the value of its assets and of potential future royalty payments from an agreement with Moderna.The board in March approved cutting 42 full-time employees, which represents 95% of its total workforce, Carisma said in a filing with the Securities and Exchange Commission. That came after the company cut 62 jobs in 2024.Strategic alternatives could include selling or licensing its assets, or merging with another company, Carisma said.Carisma estimates it has cash and cash equivalents sufficient to fund operations into the second half of 2025.Shares fell 6% to a 52-week low of 31 cents after markets closed Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CARM"],"gpt_icon":0},{"id":"2524977514","title":"Carisma Therapeutics Inc: Has Paused All Research and Development Activities at This Time, Pending Outcome of Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2524977514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524977514?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:30","pubTimestamp":1743453028,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1FM:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CARM"],"gpt_icon":0},{"id":"2524977510","title":"Carisma Therapeutics Inc: Has Reduced Operations to Core Functions Necessary to Support This Strategic Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2524977510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524977510?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:30","pubTimestamp":1743453028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1FM:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CARM","BK4139"],"gpt_icon":0},{"id":"2524972766","title":"Carisma Therapeutics Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2524972766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524972766?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:30","pubTimestamp":1743453028,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CARM"],"gpt_icon":0},{"id":"2524972740","title":"Carisma Therapeutics Inc: Estimates That It Has Cash and Cash Equivalents Sufficient to Fund Its Operations Into Second Half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524972740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524972740?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:30","pubTimestamp":1743453028,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1FM:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CARM"],"gpt_icon":0},{"id":"2524775179","title":"Carisma : May Engage External Advisors to Support Evaluation of Strategic Alternatives, Prepare for Potential Wind-Down of Operations, IF Necessary","url":"https://stock-news.laohu8.com/highlight/detail?id=2524775179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524775179?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:30","pubTimestamp":1743453028,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1FM:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CARM"],"gpt_icon":0},{"id":"2524727459","title":"Carisma Therapeutics Inc: Has Reduced Its Workforce, Retaining Only Those Employees Deemed Essential to Pursue Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2524727459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524727459?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:30","pubTimestamp":1743453028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1FM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CARM","BK4139"],"gpt_icon":0},{"id":"2524727339","title":"Carisma Therapeutics Inc: to Explore Strategic Alternatives to Advance Liver Fibrosis and Oncology Assets and Reduce Operational Cash Burn","url":"https://stock-news.laohu8.com/highlight/detail?id=2524727339","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524727339?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:30","pubTimestamp":1743453028,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1FM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CARM","BK4139"],"gpt_icon":0},{"id":"2524942977","title":"Carisma Therapeutics Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2524942977","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524942977?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:30","pubTimestamp":1743453000,"startTime":"0","endTime":"0","summary":"Company to explore strategic alternatives to advance liver fibrosis and oncology assets and reduce operational cash burn. PHILADELPHIA, March 31, 2025 /PRNewswire/ -- Carisma Therapeutics Inc.   today announced that its Board of Directors has approved a revised operating plan focused on evaluating strategic alternatives while reducing operational cash burn.The Company's goal is to maximize the value of its assets, including its liver fibrosis and oncology development programs, its macrophage and monocyte engineering platform and the CAR-M platform and to realize value from the potential future milestone and royalty payments under Carisma's agreement with Moderna. To support this transition, the Company has reduced its workforce, retaining only those employees deemed essential to pursue strategic alternatives. With these actions, the Company estimates that it has cash and cash equivalents sufficient to fund its operations into the second half of 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/carisma-therapeutics-provides-corporate-updates-203000178.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/carisma-therapeutics-provides-corporate-updates-203000178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CARM","BK4139"],"gpt_icon":0},{"id":"2522757173","title":"Carisma Therapeutics Inc  expected to post a loss of 16 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522757173","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522757173?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:00","pubTimestamp":1743166823,"startTime":"0","endTime":"0","summary":"Carisma Therapeutics Inc  expected to post a loss of16cents a share - Earnings Preview Carisma Therapeutics Inc CARM.OQ CARM.O is expected to show a rise in quarterly revenue when it reports  results ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB116:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARM"],"gpt_icon":1},{"id":"2517113146","title":"Carmila SAS (CARM) Receives a Buy from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113146","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517113146?lang=en_us&edition=fundamental","pubTime":"2025-03-07 09:37","pubTimestamp":1741311464,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst Benjamin Legrand maintained a Buy rating on Carmila SAS (CARM – Research Report) on March 5 and set a price target of €22.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/carmila-sas-carm-receives-a-buy-from-kepler-capital-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/carmila-sas-carm-receives-a-buy-from-kepler-capital-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CARM"],"gpt_icon":0},{"id":"2511768347","title":"Kepler Capital  Sticks to Its Buy Rating for Carmila SAS (CARM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511768347","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511768347?lang=en_us&edition=fundamental","pubTime":"2025-02-14 09:37","pubTimestamp":1739497038,"startTime":"0","endTime":"0","summary":"In a report released on February 12, Benjamin Legrand from Kepler Capital maintained a Buy rating on Carmila SAS (CARM – Research Report), with a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-buy-rating-for-carmila-sas-carm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-buy-rating-for-carmila-sas-carm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CARM"],"gpt_icon":0},{"id":"2503013283","title":"Carisma Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2503013283","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503013283?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:17","pubTimestamp":1736774220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CARM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2025 08:17 ET (13:17 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARM"],"gpt_icon":0},{"id":"2494186868","title":"BRIEF-Carisma Therapeutics Appoints Natalie Mcandrew As Principal Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2494186868","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494186868?lang=en_us&edition=fundamental","pubTime":"2024-12-27 05:45","pubTimestamp":1735249547,"startTime":"0","endTime":"0","summary":"BRIEF-Carisma Therapeutics Appoints Natalie Mcandrew As Principal Financial OfficerDec 26 (Reuters) - Carisma Therapeutics Inc CARM.O:CARISMA THERAPEUTICS INC: ON DEC 24, APPOINTS NATALIE MCANDREW AS PRINCIPAL FINANCIAL OFFICERFurther company coverage: CARM.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241226:nFWN3NR03E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CARM"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":69,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CARM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"CARM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-07","symbol":"CARM","fiscalQuarterEnding":"2024/09","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.31},{"market":"US","date":"2024-08-08","symbol":"CARM","fiscalQuarterEnding":"2024/06","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2024-05-09","symbol":"CARM","fiscalQuarterEnding":"2024/03","expectedEps":-0.37,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2024-04-01","symbol":"CARM","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711944000000,"reportTimeType":"pre","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CARM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CARM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.6667,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":3,"updateTime":1736481600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CARM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CARM","date":"2025-04-23","current":-0.146418,"percent":0.978218,"low":-5.12389,"twenty":-2.807425,"median":-1.025276,"eighty":-0.526861,"high":-0.121612,"avg":-1.457762,"sd":1.251979,"marketCap":8854897},"quantilePoints":[{"date":"2023-03-10","current":-3.207819,"twenty":-3.598679,"median":-3.563146,"eighty":-3.34995,"marketCap":130827684},{"date":"2023-03-17","current":-3.079506,"twenty":-3.4526,"median":-3.183143,"eighty":-3.113065,"marketCap":125594576},{"date":"2023-03-24","current":-3.168338,"twenty":-3.255196,"median":-3.118987,"eighty":-2.889997,"marketCap":129217477},{"date":"2023-03-31","current":-3.059765,"twenty":-3.192027,"median":-3.094311,"eighty":-2.917634,"marketCap":124789464},{"date":"2023-04-06","current":-2.901842,"twenty":-3.166364,"median":-3.069635,"eighty":-2.909738,"marketCap":118348718},{"date":"2023-04-14","current":-2.038178,"twenty":-3.15452,"median":-3.049895,"eighty":-2.846569,"marketCap":124789464},{"date":"2023-04-21","current":-2.807425,"twenty":-3.134779,"median":-2.975868,"eighty":-2.644371,"marketCap":171887423},{"date":"2023-04-28","current":-2.656206,"twenty":-3.118987,"median":-2.921582,"eighty":-2.629907,"marketCap":162628850},{"date":"2023-05-05","current":-3.353131,"twenty":-3.138727,"median":-2.901842,"eighty":-2.636481,"marketCap":205298796},{"date":"2023-05-12","current":-3.714743,"twenty":-3.207819,"median":-2.975868,"eighty":-2.656206,"marketCap":227438862},{"date":"2023-05-19","current":-3.030967,"twenty":-3.286781,"median":-3.049895,"eighty":-2.67593,"marketCap":185574010},{"date":"2023-05-26","current":-2.591641,"twenty":-3.286781,"median":-3.040431,"eighty":-2.67593,"marketCap":193222396},{"date":"2023-05-31","current":-2.694227,"twenty":-3.263353,"median":-3.030967,"eighty":-2.68119,"marketCap":200870783},{"date":"2023-06-08","current":-3.196357,"twenty":-3.345241,"median":-3.05483,"eighty":-2.690109,"marketCap":238307622},{"date":"2023-06-16","current":-3.995447,"twenty":-3.440944,"median":-3.079506,"eighty":-2.697142,"marketCap":297884528},{"date":"2023-06-23","current":-4.924118,"twenty":-3.563146,"median":-3.109117,"eighty":-2.708804,"marketCap":367122553},{"date":"2023-06-30","current":-4.843129,"twenty":-3.680142,"median":-3.118987,"eighty":-2.724583,"marketCap":361084354},{"date":"2023-07-07","current":-4.55157,"twenty":-3.877471,"median":-3.142738,"eighty":-2.756142,"marketCap":339346834},{"date":"2023-07-14","current":-4.859327,"twenty":-4.187278,"median":-3.168688,"eighty":-2.787908,"marketCap":362291994},{"date":"2023-07-21","current":-4.778338,"twenty":-4.47382,"median":-3.201911,"eighty":-2.80318,"marketCap":356253794},{"date":"2023-07-28","current":-3.088372,"twenty":-4.47382,"median":-3.204865,"eighty":-2.820495,"marketCap":230256689},{"date":"2023-08-04","current":-2.931794,"twenty":-4.419828,"median":-3.169038,"eighty":-2.837256,"marketCap":218582836},{"date":"2023-08-11","current":-3.204157,"twenty":-4.40147,"median":-3.163403,"eighty":-2.847531,"marketCap":238889130},{"date":"2023-08-18","current":-3.2042,"twenty":-4.345825,"median":-3.178891,"eighty":-2.857739,"marketCap":255003068},{"date":"2023-08-25","current":-3.305439,"twenty":-4.268267,"median":-3.186484,"eighty":-2.865146,"marketCap":263060037},{"date":"2023-09-01","current":-3.502854,"twenty":-4.157424,"median":-3.201911,"eighty":-2.876062,"marketCap":278771127},{"date":"2023-09-08","current":-2.515778,"twenty":-4.060238,"median":-3.194076,"eighty":-2.855427,"marketCap":200215679},{"date":"2023-09-15","current":-2.432256,"twenty":-3.993621,"median":-3.168688,"eighty":-2.801058,"marketCap":193568680},{"date":"2023-09-22","current":-2.014647,"twenty":-3.960313,"median":-3.153581,"eighty":-2.700058,"marketCap":160333683},{"date":"2023-09-29","current":-2.267744,"twenty":-3.8898,"median":-3.140732,"eighty":-2.664096,"marketCap":180476105},{"date":"2023-10-06","current":-2.217124,"twenty":-3.832117,"median":-3.116439,"eighty":-2.601687,"marketCap":176447621},{"date":"2023-10-13","current":-1.670436,"twenty":-3.766542,"median":-3.099247,"eighty":-2.527927,"marketCap":132939988},{"date":"2023-10-20","current":-1.490738,"twenty":-3.697443,"median":-3.079506,"eighty":-2.412515,"marketCap":118638868},{"date":"2023-10-27","current":-1.437587,"twenty":-3.680142,"median":-3.059765,"eighty":-2.384168,"marketCap":114408959},{"date":"2023-11-03","current":-1.52364,"twenty":-3.648235,"median":-3.044837,"eighty":-2.294066,"marketCap":121257383},{"date":"2023-11-10","current":-1.289683,"twenty":-3.626379,"median":-3.030967,"eighty":-2.181185,"marketCap":106605233},{"date":"2023-11-17","current":-1.230331,"twenty":-3.57499,"median":-3.018182,"eighty":-2.131577,"marketCap":101699151},{"date":"2023-11-24","current":-1.20592,"twenty":-3.545193,"median":-3.001984,"eighty":-2.056155,"marketCap":99681310},{"date":"2023-12-01","current":-1.171744,"twenty":-3.518998,"median":-2.961063,"eighty":-1.996997,"marketCap":96856334},{"date":"2023-12-08","current":-1.244978,"twenty":-3.505518,"median":-2.916818,"eighty":-1.804922,"marketCap":102909855},{"date":"2023-12-15","current":-1.323094,"twenty":-3.478557,"median":-2.8913,"eighty":-1.666386,"marketCap":109366944},{"date":"2023-12-22","current":-1.415857,"twenty":-3.456285,"median":-2.864682,"eighty":-1.547938,"marketCap":117034737},{"date":"2023-12-29","current":-1.498855,"twenty":-3.452235,"median":-2.850805,"eighty":-1.518424,"marketCap":123895394},{"date":"2024-01-05","current":-1.332858,"twenty":-3.452235,"median":-2.835914,"eighty":-1.497232,"marketCap":110174080},{"date":"2024-01-12","current":-1.269389,"twenty":-3.446589,"median":-2.796813,"eighty":-1.454396,"marketCap":104927695},{"date":"2024-01-19","current":-1.147332,"twenty":-3.444905,"median":-2.728528,"eighty":-1.425858,"marketCap":94838494},{"date":"2024-01-26","current":-1.078981,"twenty":-3.433385,"median":-2.693587,"eighty":-1.391796,"marketCap":89188541},{"date":"2024-02-02","current":-1.054569,"twenty":-3.417727,"median":-2.67593,"eighty":-1.356293,"marketCap":87170700},{"date":"2024-02-09","current":-1.025276,"twenty":-3.411974,"median":-2.633194,"eighty":-1.311376,"marketCap":84749292},{"date":"2024-02-16","current":-1.118039,"twenty":-3.392354,"median":-2.591641,"eighty":-1.282083,"marketCap":92417085},{"date":"2024-02-23","current":-1.210802,"twenty":-3.36891,"median":-2.530964,"eighty":-1.255719,"marketCap":100084878},{"date":"2024-03-01","current":-1.259624,"twenty":-3.352277,"median":-2.52084,"eighty":-1.242048,"marketCap":104120559},{"date":"2024-03-08","current":-1.210802,"twenty":-3.33607,"median":-2.432256,"eighty":-1.242048,"marketCap":100084878},{"date":"2024-03-15","current":-1.20592,"twenty":-3.310385,"median":-2.368982,"eighty":-1.230331,"marketCap":99681310},{"date":"2024-03-22","current":-1.225449,"twenty":-3.305439,"median":-2.313301,"eighty":-1.217637,"marketCap":101295583},{"date":"2024-03-28","current":-1.093627,"twenty":-3.303414,"median":-2.267744,"eighty":-1.211778,"marketCap":90399245},{"date":"2024-04-05","current":-0.918078,"twenty":-3.294961,"median":-2.200673,"eighty":-1.20592,"marketCap":79761665},{"date":"2024-04-12","current":-0.946768,"twenty":-3.292191,"median":-2.166505,"eighty":-1.196155,"marketCap":82254217},{"date":"2024-04-19","current":-0.817663,"twenty":-3.275067,"median":-2.117151,"eighty":-1.191273,"marketCap":71037733},{"date":"2024-04-26","current":-0.784191,"twenty":-3.224132,"median":-2.060205,"eighty":-1.182484,"marketCap":68129755},{"date":"2024-05-03","current":-0.765069,"twenty":-3.207095,"median":-2.026413,"eighty":-1.169791,"marketCap":66468390},{"date":"2024-05-10","current":-0.772389,"twenty":-3.204191,"median":-1.994399,"eighty":-1.158073,"marketCap":62729543},{"date":"2024-05-17","current":-0.700776,"twenty":-3.203708,"median":-1.857372,"eighty":-1.134639,"marketCap":56913559},{"date":"2024-05-24","current":-0.64451,"twenty":-3.2008,"median":-1.731179,"eighty":-1.122921,"marketCap":52343857},{"date":"2024-05-31","current":-0.670086,"twenty":-3.196357,"median":-1.670436,"eighty":-1.108274,"marketCap":54420994},{"date":"2024-06-07","current":-0.567782,"twenty":-3.194076,"median":-1.607162,"eighty":-1.093627,"marketCap":46112445},{"date":"2024-06-14","current":-0.598473,"twenty":-3.181928,"median":-1.543888,"eighty":-1.053593,"marketCap":48605010},{"date":"2024-06-21","current":-0.516631,"twenty":-3.172979,"median":-1.518482,"eighty":-1.036017,"marketCap":41958171},{"date":"2024-06-28","current":-0.65474,"twenty":-3.169038,"median":-1.515944,"eighty":-1.025276,"marketCap":53174712},{"date":"2024-07-05","current":-0.711007,"twenty":-3.168478,"median":-1.494797,"eighty":-1.008676,"marketCap":57744414},{"date":"2024-07-12","current":-0.613819,"twenty":-3.160442,"median":-1.473021,"eighty":-0.961113,"marketCap":49851292},{"date":"2024-07-15","current":-0.613819,"twenty":-3.158468,"median":-1.463968,"eighty":-0.961113,"marketCap":49851292},{"date":"2024-08-02","current":-0.526861,"twenty":-3.157491,"median":-1.454915,"eighty":-0.949637,"marketCap":42789026},{"date":"2024-08-09","current":-0.516269,"twenty":-3.151556,"median":-1.435056,"eighty":-0.919034,"marketCap":37430012},{"date":"2024-08-16","current":-0.601678,"twenty":-3.143313,"median":-1.406092,"eighty":-0.857437,"marketCap":43622223},{"date":"2024-08-23","current":-0.681901,"twenty":-3.141936,"median":-1.391738,"eighty":-0.812881,"marketCap":49438520},{"date":"2024-08-30","current":-0.624599,"twenty":-3.134779,"median":-1.362152,"eighty":-0.787061,"marketCap":45284022},{"date":"2024-09-06","current":-0.571021,"twenty":-3.118987,"median":-1.347505,"eighty":-0.779414,"marketCap":41399567},{"date":"2024-09-13","current":-0.561852,"twenty":-3.116439,"median":-1.327976,"eighty":-0.772389,"marketCap":40734847},{"date":"2024-09-20","current":-0.56191,"twenty":-3.115616,"median":-1.289683,"eighty":-0.757043,"marketCap":40739002},{"date":"2024-09-27","current":-0.565921,"twenty":-3.109117,"median":-1.281595,"eighty":-0.726352,"marketCap":41029817},{"date":"2024-10-04","current":-0.532914,"twenty":-3.089376,"median":-1.269389,"eighty":-0.716283,"marketCap":38636826},{"date":"2024-10-11","current":-0.534633,"twenty":-3.088372,"median":-1.264507,"eighty":-0.710553,"marketCap":38761461},{"date":"2024-10-18","current":-0.572912,"twenty":-3.079506,"median":-1.259624,"eighty":-0.681901,"marketCap":41536666},{"date":"2024-10-25","current":-0.571766,"twenty":-3.059765,"median":-1.247419,"eighty":-0.66497,"marketCap":41453576},{"date":"2024-10-31","current":-0.573026,"twenty":-3.059765,"median":-1.242536,"eighty":-0.658132,"marketCap":41544975},{"date":"2024-11-08","current":-0.67071,"twenty":-3.051869,"median":-1.235213,"eighty":-0.64752,"marketCap":42791324},{"date":"2024-11-15","current":-0.611388,"twenty":-3.041802,"median":-1.230331,"eighty":-0.646918,"marketCap":39006577},{"date":"2024-11-22","current":-0.554792,"twenty":-3.039779,"median":-1.220566,"eighty":-0.633045,"marketCap":35395742},{"date":"2024-11-29","current":-0.55898,"twenty":-3.034492,"median":-1.215684,"eighty":-0.613819,"marketCap":35662943},{"date":"2024-12-06","current":-0.518277,"twenty":-3.030967,"median":-1.210802,"eighty":-0.608704,"marketCap":33066086},{"date":"2024-12-13","current":-0.317379,"twenty":-3.023296,"median":-1.20592,"eighty":-0.598473,"marketCap":20248802},{"date":"2024-12-20","current":-0.288913,"twenty":-3.018182,"median":-1.201037,"eighty":-0.588243,"marketCap":18432673},{"date":"2024-12-27","current":-0.289241,"twenty":-3.013863,"median":-1.193714,"eighty":-0.580505,"marketCap":18453548},{"date":"2025-01-03","current":-0.287997,"twenty":-3.005224,"median":-1.191273,"eighty":-0.578756,"marketCap":18374222},{"date":"2025-01-10","current":-0.310246,"twenty":-2.996585,"median":-1.191273,"eighty":-0.578756,"marketCap":19793726},{"date":"2025-01-17","current":-0.298729,"twenty":-2.990674,"median":-1.18639,"eighty":-0.573026,"marketCap":19058924},{"date":"2025-01-24","current":-0.289306,"twenty":-2.966985,"median":-1.176626,"eighty":-0.573026,"marketCap":18457723},{"date":"2025-01-31","current":-0.326541,"twenty":-2.945271,"median":-1.170523,"eighty":-0.572878,"marketCap":20833304},{"date":"2025-02-07","current":-0.327195,"twenty":-2.9337,"median":-1.166861,"eighty":-0.571342,"marketCap":20875054},{"date":"2025-02-14","current":-0.310639,"twenty":-2.907832,"median":-1.155876,"eighty":-0.566563,"marketCap":19818776},{"date":"2025-02-21","current":-0.302786,"twenty":-2.901842,"median":-1.144891,"eighty":-0.562254,"marketCap":19317775},{"date":"2025-02-28","current":-0.2683,"twenty":-2.895517,"median":-1.132686,"eighty":-0.560993,"marketCap":17117544},{"date":"2025-03-07","current":-0.258484,"twenty":-2.885781,"median":-1.122921,"eighty":-0.558743,"marketCap":16491293},{"date":"2025-03-14","current":-0.262869,"twenty":-2.873042,"median":-1.118039,"eighty":-0.556127,"marketCap":16771018},{"date":"2025-03-21","current":-0.272096,"twenty":-2.864218,"median":-1.105833,"eighty":-0.552829,"marketCap":17359695},{"date":"2025-03-28","current":-0.234141,"twenty":-2.855427,"median":-1.093627,"eighty":-0.548512,"marketCap":14938189},{"date":"2025-04-04","current":-0.132616,"twenty":-2.845895,"median":-1.064334,"eighty":-0.541006,"marketCap":8020195},{"date":"2025-04-11","current":-0.137504,"twenty":-2.834573,"median":-1.044805,"eighty":-0.534289,"marketCap":8315831},{"date":"2025-04-17","current":-0.138817,"twenty":-2.820495,"median":-1.030158,"eighty":-0.527747,"marketCap":8395228},{"date":"2025-04-23","current":-0.146418,"twenty":-2.807425,"median":-1.025276,"eighty":-0.526861,"marketCap":8854897}],"updateTime":1745558115688}}}